Nanyang Biologics SEC filing clears path for Nasdaq listing

August 11, 2026 8:30 AM

Nanyang Biologics Pte. Ltd. (NYB), a Singapore-based drug discovery company, has received a notice of effectiveness from the U.S. Securities ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found